# Comparative Effectiveness of Psoriasis Treatments on Systemic Inflammation

> **NCT02330380** · — · COMPLETED · sponsor: **University Hospitals Cleveland Medical Center** · enrollment: 26 (actual)

## Conditions studied

- Psoriasis
- Inflammation

## Interventions

- **DRUG:** Methotrexate
- **DRUG:** Ustekinumab
- **DRUG:** Etanercept
- **DRUG:** Adalimumab
- **DRUG:** Acitretin
- **OTHER:** UVB Excimer Laser
- **OTHER:** Narrowband UVB

## Key facts

- **NCT ID:** NCT02330380
- **Lead sponsor:** University Hospitals Cleveland Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2017-10-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02330380

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02330380, "Comparative Effectiveness of Psoriasis Treatments on Systemic Inflammation". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02330380. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*